Browse > Article
http://dx.doi.org/10.3904/kjim.2015.30.1.23

Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?  

Kim, Ji Hoon (Department of Internal Medicine, Korea University Guro Hospital)
Lee, June Sung (Department of Internal Medicine, Inje University Ilsan Paik Hospital)
Publication Information
The Korean journal of internal medicine / v.30, no.1, 2015 , pp. 23-26 More about this Journal
Keywords
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008;359:2442-2455.   DOI
2 Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 2013;381:468-475.   DOI
3 Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351:1521-1531.   DOI
4 Seto WK, Liu K, Fung J, et al. Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir. Antivir Ther 2012;17:1255-1262.   DOI
5 European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57:167-185.   DOI
6 Qi X, Xiong S, Yang H, Miller M, Delaney WE 4th. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther 2007;12:355-362.
7 Korean Association for the Study of the Liver. KASL Clinical Practice Guidelines: management of chronic hepatitis B. Clin Mol Hepatol 2012;18:109-162.   DOI
8 Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-662.   DOI
9 van Bommel F, de Man RA, Wedemeyer H, et al. Longterm efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues. Hepatology 2010;51:73-80.   DOI
10 Fung S, Kwan P, Fabri M, et al. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 2014;146:980-988.   DOI
11 Lim YS, Yoo BC, Byun KS, et al. Randomized trial of tenofovir monotherapy versus tenofovir plus entecavir combination therapy in chronic hepatitis B patients with genotypic resistance mutations to adefovir. J Hepatol 2014;60(1 Suppl):S431.
12 Kim HJ, Cho JY, Kim YJ, et al. Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients. Korean J Intern Med 2015;30:32-41.   DOI
13 Kwon SY, Yoo BC, Byun KS, et al. Tenofovir is effective alone or with entecavir in entecavir-resistant patients with chronic-hepatitis B virus infection: multicenter randomized trial. Clin Mol Hepatol 2014;20:S5.